A pilot program begun during the COVID-19 pandemic to allow New Jersey residents with cancer to receive chemotherapy infusions at home was so successful that it has become standard practice, representatives from Horizon Blue Cross Blue Shield of New Jersey said during the AMCP Nexus 2023 meeting, in Orlando, Fla.
The program, a partnership between Horizon, Rutgers Cancer Institute of New Jersey (part of RWJBarnabas Health) and Qualitas Home Infusion (also part of RWJBarnabas Health),